hitconsultant.net
type: channel
date: 2026-04-15T20:38:13Z
update period: hourly
update frequency: 1
update base: 2000-01-01T12:00+00:00
generator agent: https://wordpress.org/
items: Why Hospital Dashboards Tell the Future But Operations Remain Stuck in the Past
items: Why Abridge is Embedding NEJM and JAMA Directly into the EHR
items: Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment
items: Osteoboost Health Raises $8M for FDA-Cleared Bone Density Device
items: The Clinical Resolution Gap: Why AI Can’t Fix Broken MSK Care Platforms
items: AliveCor Secures CE Mark for Kardia 12L AI-Powered ECG System in Europe
items: HHS Launches $4M EMPOWER Prize Challenge to Enhance Living Kidney Donation
items: CMS Establishes New Billing Code for AI-Driven Calcium Analysis on CT Scans
items: Wavelet Medical Secures $7M to Scale AI Fetal Brain Monitoring Globally with Aegis Ventures
items: Finding the Right Five Percent: How Machine Learning Is Reshaping Care Management
items: Ultralight Raises $9.3M to Launch AI-Native Operating System for Healthcare
items: The AI Arms Race: Why PHTI Warns Healthcare ‘Bot Wars’ Are Inflating Medical Costs
items: ModMed Expands Multi-Year Cloud Agreement with AWS to Scale Healthcare AI Solutions
items: symplr Appoints Former Edifecs Executive Venkat Kavarthapu as CEO
items: The Push for Side-by-Side Prescription Pricing in EHR Workflows

Why Hospital Dashboards Tell the Future But Operations Remain Stuck in the Past
type: item
creator: Osama Usmani, Founder and CEO, Salubrum
date: 2026-04-16T07:18:00Z
subject: Health IT
subject: Opinion
subject: Artificial Intelligence
description: Over the past decade, health systems have poured sustained capital and attention into data infrastructure. Enterprise warehouses consolidated fragmented reporting environments. Interoperability initiatives linked EHR instances that had operated in parallel for years. Population health platforms brought predictive modeling into conversations about utilization and risk. Dashboards became ubiquitous, appearing in service line reviews, access meetings, ... Read More
encoded: <img width="1500" height="1000" src="https://hitconsultant.net/wp-content/uploads/2026/04/Osama-Usmani_headshot-1500x1000.jpg" alt="Why Hospital Dashboards Tell the Future But Operations Remain Stuck in the Past" class="wp-image-95737" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/Osama-Usmani_headshot-1500x1000.jpg 1500w, https://hitconsultant.net/wp-content/uploads/2026/04/Osama-Usmani_headshot-300x200.jpg 300w, https://hitconsultant.net/wp-content/uploads/2026/04/Osama-Usmani_headshot-290x193.jpg 290w, https://hitconsultant.net/wp-content/uploads/2026/04/Osama-Usmani_headshot-768x512.jpg 768w, https://hitconsultant.net/wp-content/uploads/2026/04/Osama-Usmani_headshot-1536x1024.jpg 1536w, https://hitconsultant.net/wp-content/uploads/2026/04/Osama-Usmani_headshot-2048x1365.jpg 2048w" sizes="(max-width: 1500px) 100vw, 1500px" /> Osama Usmani, Founder and CEO, Salubrum Over the past decade, health systems have poured sustained capital and attention into data infrastructure. Enterprise warehouses consolidated fragmented reporting environments. Interoperability initiatives linked EHR instances that had operated in parallel for years. Population health platforms brought predictive modeling into conversations about utilization and risk. Dashboards became ubiquitous, appearing in service line reviews, access meetings, finance updates, and clinical leadership forums. In technical terms, most large systems are no longer constrained by data scarcity. If anything, they operate amid an abundance of signal that existing planning processes were never redesigned to absorb. That abundance has not translated evenly into decision authority. In many organizations, intelligence still functions primarily as a reporting layer. Dashboards are reviewed quarterly. Predictive models are circulated before planning sessions. The discussion is often informed by them. The decisions that follow, however, are more frequently anchored in precedent, historical patterns, and negotiate…

Why Abridge is Embedding NEJM and JAMA Directly into the EHR
type: item
creator: Fred Pennic
date: 2026-04-15T17:38:09Z
subject: EMR/EHR
subject: Health IT
subject: Artificial Intelligence
description: What You Should Know The Partnerships: Enterprise AI platform Abridge has secured multi-year content partnerships with the NEJM Group (publisher of the New England Journal of Medicine) and the American Medical Association (publisher of the JAMA Network). The Workflow Shift: The integration allows clinicians to ask complex clinical questions and receive evidence-based answers directly within ... Read More
encoded: <img loading="lazy" width="1500" height="742" src="https://hitconsultant.net/wp-content/uploads/2026/04/Abridge-1500x742.png" alt="Why Abridge is Embedding NEJM and JAMA Directly into the EHR" class="wp-image-95763" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/Abridge-1500x742.png 1500w, https://hitconsultant.net/wp-content/uploads/2026/04/Abridge-300x148.png 300w, https://hitconsultant.net/wp-content/uploads/2026/04/Abridge-290x143.png 290w, https://hitconsultant.net/wp-content/uploads/2026/04/Abridge-768x380.png 768w, https://hitconsultant.net/wp-content/uploads/2026/04/Abridge-1536x759.png 1536w, https://hitconsultant.net/wp-content/uploads/2026/04/Abridge-2048x1013.png 2048w, https://hitconsultant.net/wp-content/uploads/2026/04/Abridge-515x255.png 515w" sizes="(max-width: 1500px) 100vw, 1500px" /> What You Should Know The Partnerships: Enterprise AI platform Abridge has secured multi-year content partnerships with the NEJM Group (publisher of the New England Journal of Medicine) and the American Medical Association (publisher of the JAMA Network). The Workflow Shift: The integration allows clinicians to ask complex clinical questions and receive evidence-based answers directly within their existing workflow. Historically, finding this literature required breaking focus, leaving the EHR, and searching external databases. The Context Engine: The Abridge Clinical Decision Support (CDS) system will now surface insights that are grounded in both elite peer-reviewed research and the specific patient context captured during the ambient listening phase of the encounter. Context-Aware Insights in Real Time Historically, clinicians seeking reliable research during an encounter had to step away from the patient, open separate tools, and perform manual searches. The Abridge platform solves this “workflow friction” by integrating content from the New England Journal of Medicine, JAMA, and 11 specialty journals directly into its AI-powered system. This integra…

Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment
type: item
creator: Fred Pennic
date: 2026-04-15T15:30:00Z
subject: Digital Health
subject: Startups
subject: Cancer Diagnostics
subject: Oncology Digital Health Startups
subject: Oncology Platform
description: What You Should Know The Raise: Clinical-stage medical device company Sonire Therapeutics has announced an $18M Series A financing round. The round was led by Santé Ventures, with participation from Fast Track Initiative (FTI), Nomura SPARX Investment, and SBI Investment. The Technology: Sonire has developed a proprietary High-Intensity Focused Ultrasound (HIFU) therapy system for the ... Read More
encoded: <img loading="lazy" width="1500" height="423" src="https://hitconsultant.net/wp-content/uploads/2026/04/Sonire_Logo.jpg" alt="Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment" class="wp-image-95767" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/Sonire_Logo.jpg 1500w, https://hitconsultant.net/wp-content/uploads/2026/04/Sonire_Logo-300x85.jpg 300w, https://hitconsultant.net/wp-content/uploads/2026/04/Sonire_Logo-290x82.jpg 290w, https://hitconsultant.net/wp-content/uploads/2026/04/Sonire_Logo-768x217.jpg 768w" sizes="(max-width: 1500px) 100vw, 1500px" /> What You Should Know The Raise: Clinical-stage medical device company Sonire Therapeutics has announced an $18M Series A financing round. The round was led by Santé Ventures, with participation from Fast Track Initiative (FTI), Nomura SPARX Investment, and SBI Investment. The Technology: Sonire has developed a proprietary High-Intensity Focused Ultrasound (HIFU) therapy system for the non-invasive thermal ablation of solid tumors. The Clinical Target: The company is initially focusing on pancreatic cancer, a notoriously lethal disease with a 5-year survival rate of only 12% and very limited local therapy options. The device received an FDA Breakthrough Device Designation in 2024. The Workflow Disruption: Unlike conventional ultrasound-guided HIFU systems, Sonire’s solution provides clear real-time visualization, requires no anesthesia, and can be performed on an outpatient basis in roughly 20 minutes. It also only requires one physician to administer, drastically lowering the staffing burden. A New Approach to Lethal Solid Tumors Pancreatic cancer remains a devastating diagnosis with a 5-year survival rate of just 12%. Current local therapy options are limited, leaving a high unmet medical need for patients. Sonire’s proprietary HIFU system is designed to prolong survival when combined with chemotherapy, offering a safer alternative to traditional surgery or radiation. Unlike co…

Osteoboost Health Raises $8M for FDA-Cleared Bone Density Device
type: item
creator: Jasmine Pennic
date: 2026-04-15T15:12:00Z
subject: Digital Health
subject: Startups
description: What You Should Know The Raise: Osteoboost Health has closed an $8M financing round led by Ambit Health Ventures, with participation from Emmeline Ventures, Disrupt Health Impact Fund, Esplanade Ventures, and Portfolia. The Device: The FDA-cleared “Osteoboost” device is a wearable belt worn low around the hips. It delivers targeted, precisely calibrated vibration therapy directly ... Read More
encoded: <img loading="lazy" width="720" height="720" src="https://hitconsultant.net/wp-content/uploads/2026/04/image-5.png" alt="Osteoboost Health Raises $8M for FDA-Cleared Bone Density Device" class="wp-image-95780" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/image-5.png 720w, https://hitconsultant.net/wp-content/uploads/2026/04/image-5-300x300.png 300w, https://hitconsultant.net/wp-content/uploads/2026/04/image-5-290x290.png 290w, https://hitconsultant.net/wp-content/uploads/2026/04/image-5-100x100.png 100w" sizes="(max-width: 720px) 100vw, 720px" /> What You Should Know The Raise: Osteoboost Health has closed an $8M financing round led by Ambit Health Ventures, with participation from Emmeline Ventures, Disrupt Health Impact Fund, Esplanade Ventures, and Portfolia. The Device: The FDA-cleared “Osteoboost” device is a wearable belt worn low around the hips. It delivers targeted, precisely calibrated vibration therapy directly to the lumbar spine and hips (the regions most vulnerable to fracture). The Clinical Gap: The device targets osteopenia, the precursor to osteoporosis. Nearly 44 million Americans live with low bone density, and bone loss accelerates rapidly during menopause. Currently, there are no approved drug therapies for osteopenia, leaving patients with few proactive options beyond calcium and exercise. The Science: The vibration therapy was inspired by NASA-funded research. In a double-blinded clinical trial, patients who used the device 3 times per week for 30-minute sessions over a 12-month period slowed bone density loss by 85% in the spine and 55% in the hips. A First-of-Its-Kind Solution for Osteopenia While nearly 54 million Americans live with osteoporosis or low bone density, few proactive options exist for women during menopause, when bone loss accelerates rapidly. Osteoboost is a class II prescription medical device and stands as the first and only FDA-cleared, non-drug treatment clinically proven to treat low bone density in postm…

The Clinical Resolution Gap: Why AI Can’t Fix Broken MSK Care Platforms
type: item
creator: Chris Cato, DC, Chief Population Health Officer at Airrosti
date: 2026-04-15T15:10:00Z
subject: Health IT
subject: Opinion
description: For years, clinicians have complained about the same thing: they became doctors to care for patients, not to stare at screens. The electronic health record inserted a keyboard into the most important relationship in medicine. Now, for the first time in decades, artificial intelligence (AI) is beginning to remove it. Ambient listening technology is giving ... Read More
encoded: <img loading="lazy" width="800" height="800" src="https://hitconsultant.net/wp-content/uploads/2026/04/Dr.-Chris-Cato-Airrosti-Headshot.jpg" alt="The Clinical Resolution Gap: Why AI Can’t Fix Broken MSK Care Platforms" class="wp-image-95734" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/Dr.-Chris-Cato-Airrosti-Headshot.jpg 800w, https://hitconsultant.net/wp-content/uploads/2026/04/Dr.-Chris-Cato-Airrosti-Headshot-300x300.jpg 300w, https://hitconsultant.net/wp-content/uploads/2026/04/Dr.-Chris-Cato-Airrosti-Headshot-290x290.jpg 290w, https://hitconsultant.net/wp-content/uploads/2026/04/Dr.-Chris-Cato-Airrosti-Headshot-768x768.jpg 768w, https://hitconsultant.net/wp-content/uploads/2026/04/Dr.-Chris-Cato-Airrosti-Headshot-100x100.jpg 100w" sizes="(max-width: 800px) 100vw, 800px" /> Chris Cato, DC, Chief Population Health Officer at Airrosti For years, clinicians have complained about the same thing: they became doctors to care for patients, not to stare at screens. The electronic health record inserted a keyboard into the most important relationship in medicine. Now, for the first time in decades, artificial intelligence (AI) is beginning to remove it. Ambient listening technology is giving providers back the focused attention that documentation demands have quietly eroded. That is not a minor workflow improvement. It is a restoration of something fundamental to good care. And yet, the most important question in healthcare AI right now is not what it is fixing. It is what it’s not fixing, and whether the industry has the discipline to tell the difference. Improving the experience of care delivery is not the same as improving the outcomes of care itself. In a healthcare economy where employers and health plans are ultimately evaluated on total cost and clinical results, conflating the two carries real consequences. Acceleration Is Not the Same as Improvement AI excels at the mechanics of healthcare delivery. It increases speed, sharpens triage, automates …

AliveCor Secures CE Mark for Kardia 12L AI-Powered ECG System in Europe
type: item
creator: Fred Pennic
date: 2026-04-15T15:00:00Z
subject: Digital Health
subject: Artificial Intelligence
description: What You Should Know The Milestone: AliveCor, a global leader in AI-powered cardiology, has secured a CE Mark (Conformité Européenne) for its Kardia 12L electrocardiogram (ECG) system, allowing it to be distributed across the European Economic Area. The Hardware Shift: The Kardia 12L effectively replaces the traditional, bulky 10-electrode ECG cart. It utilizes a unique ... Read More
encoded: <img loading="lazy" width="1500" height="1500" src="https://hitconsultant.net/wp-content/uploads/2026/04/Kardia-12L-ECG-System_Square-1500x1500.jpg" alt="AliveCor Secures CE Mark for Kardia 12L AI-Powered ECG System in Europe" class="wp-image-95766" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/Kardia-12L-ECG-System_Square-1500x1500.jpg 1500w, https://hitconsultant.net/wp-content/uploads/2026/04/Kardia-12L-ECG-System_Square-300x300.jpg 300w, https://hitconsultant.net/wp-content/uploads/2026/04/Kardia-12L-ECG-System_Square-290x290.jpg 290w, https://hitconsultant.net/wp-content/uploads/2026/04/Kardia-12L-ECG-System_Square-768x768.jpg 768w, https://hitconsultant.net/wp-content/uploads/2026/04/Kardia-12L-ECG-System_Square-1536x1536.jpg 1536w, https://hitconsultant.net/wp-content/uploads/2026/04/Kardia-12L-ECG-System_Square-2048x2048.jpg 2048w, https://hitconsultant.net/wp-content/uploads/2026/04/Kardia-12L-ECG-System_Square-100x100.jpg 100w" sizes="(max-width: 1500px) 100vw, 1500px" /> What You Should Know The Milestone: AliveCor, a global leader in AI-powered cardiology, has secured a CE Mark (Conformité Européenne) for its Kardia 12L electrocardiogram (ECG) system, allowing it to be distributed across the European Economic Area. The Hardware Shift: The Kardia 12L effectively replaces the traditional, bulky 10-electrode ECG cart. It utilizes a unique single-cable, five-electrode design, runs on batteries, and weighs just 0.13 kg (0.3 lbs). The AI Engine: The device is powered by the KAI 12L AI algorithm. Using just the reduced leadset, the AI is cleared to detect 35 cardiac determinations, including 14 arrhythmias and 21 morphologies. Crucially, this includes life-threatening conditions like acute myocardial infarction (heart attacks) and cardiac ischemia. The Clinical Workflow: Because the hardware is simplified to five electrodes, patients do not need to fully disrobe during a reading. Research indicates this design yields a nearly 30% reduction in ECG…

HHS Launches $4M EMPOWER Prize Challenge to Enhance Living Kidney Donation
type: item
creator: Jasmine Pennic
date: 2026-04-15T14:00:00Z
subject: Digital Health
subject: Health IT
subject: Startups
description: What You Should Know The Challenge: The U.S. Department of Health and Human Services (HHS) has launched the 2026 KidneyX EMPOWER Prize Challenge, a $4M national competition to accelerate innovations supporting living kidney donors. The Core Problem: The math surrounding kidney disease is incredibly bleak. Over 100,000 Americans are waitlisted for a kidney, and more ... Read More
encoded: <img loading="lazy" width="800" height="418" src="https://hitconsultant.net/wp-content/uploads/2026/04/KidneyX-Empower.jpeg" alt="HHS Launches $4M EMPOWER Prize Challenge to Revolutionize Living Kidney Donation" class="wp-image-95769" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/KidneyX-Empower.jpeg 800w, https://hitconsultant.net/wp-content/uploads/2026/04/KidneyX-Empower-300x157.jpeg 300w, https://hitconsultant.net/wp-content/uploads/2026/04/KidneyX-Empower-290x152.jpeg 290w, https://hitconsultant.net/wp-content/uploads/2026/04/KidneyX-Empower-768x401.jpeg 768w" sizes="(max-width: 800px) 100vw, 800px" /> What You Should Know The Challenge: The U.S. Department of Health and Human Services (HHS) has launched the 2026 KidneyX EMPOWER Prize Challenge, a $4M national competition to accelerate innovations supporting living kidney donors. The Core Problem: The math surrounding kidney disease is incredibly bleak. Over 100,000 Americans are waitlisted for a kidney, and more than a dozen die each day waiting. Despite being one of the most effective treatments, the number of living kidney donors has remained virtually flat at fewer than 7,000 per year for two decades. The Innovation Targets: The $4 million prize seeks solutions across five specific barriers: Public Awareness, Donor Interventions (addressing surgery fears), Donor Readiness (BMI management, smoking cessation, financial planning), Donor-Centered Outcomes (long-term tracking), and Center Practices (reducing administrative delays). Breaking Barriers to Living Donation The EMPOWER Prize Challenge, managed through the Kidney Innovation Accelerator (KidneyX), directly targets the financial, logistical, and educational hurdles that prevent potential donors from coming forward. The competition seeks practical solutions in five key areas: Public Awareness & Mentorship: Building community-based models to identify and support potential donors. Donor Interventions: Creating educational tools to address sur…

CMS Establishes New Billing Code for AI-Driven Calcium Analysis on CT Scans
type: item
creator: Jasmine Pennic
date: 2026-04-15T13:30:00Z
subject: Digital Health
subject: Health IT
subject: Artificial Intelligence
description: What You Should Know The Reimbursement Milestone: Effective April 1, 2026, the Centers for Medicare and Medicaid Services (CMS) has established a new national billing code and payment pathway under the Hospital Outpatient Prospective Payment System (OPPS) for the algorithmic analysis of coronary artery calcium (CAC) and aortic valve calcium (AVC) on chest CT scans. ... Read More
encoded: <img loading="lazy" width="1200" height="630" src="https://hitconsultant.net/wp-content/uploads/2026/04/image-4.png" alt="CMS Establishes New Billing Code for AI-Driven Calcium Analysis on CT Scans" class="wp-image-95771" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/image-4.png 1200w, https://hitconsultant.net/wp-content/uploads/2026/04/image-4-300x158.png 300w, https://hitconsultant.net/wp-content/uploads/2026/04/image-4-290x152.png 290w, https://hitconsultant.net/wp-content/uploads/2026/04/image-4-768x403.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /> What You Should Know The Reimbursement Milestone: Effective April 1, 2026, the Centers for Medicare and Medicaid Services (CMS) has established a new national billing code and payment pathway under the Hospital Outpatient Prospective Payment System (OPPS) for the algorithmic analysis of coronary artery calcium (CAC) and aortic valve calcium (AVC) on chest CT scans. The FDA Clearance: In tandem with the CMS news, Bunkerhill Health received FDA clearance for Bunkerhill Contrast CAC and Bunkerhill Contrast AVC. These are the first and only AI algorithms cleared to detect and quantify calcium on contrast-enhanced, routine non-gated chest CT scans. The Agentic Workflow: The algorithms live within Carebricks, Bunkerhill’s agentic AI platform. When the AI detects dangerous calcium levels, Carebricks allows the health system to deploy “AI agents” to automatically initiate cardiology referrals, coordinate follow-up care, and message providers. Expanding Diagnostic Capabilities via FDA Clearance In tandem with the reimbursement milestone, Bunkerhill received FDA clearance for Bunkerhill Contrast CAC and Bunkerhill Contrast AVC. These represent the first and only AI algorithms cleared to detect and quantify calcium on contrast-enhanced, routine non-gated chest CT scans. This clearance significantly expands the utility of imaging that patients already receive. Previously, automated calcium quantification …

Wavelet Medical Secures $7M to Scale AI Fetal Brain Monitoring Globally with Aegis Ventures
type: item
creator: Jasmine Pennic
date: 2026-04-14T15:11:00Z
subject: Digital Health
subject: Health IT
subject: Startups
description: What You Should Know The Raise & Partnership: Wavelet Medical, an AI-powered fetal brain monitoring startup spun out of Yale, has raised $7M in seed funding and entered into a co-creation partnership with the venture studio Aegis Ventures. The Solution: Wavelet has developed the first non-invasive, AI-powered fetal electroencephalography (EEG) monitoring platform. Instead of looking ... Read More
encoded: <img loading="lazy" width="1500" height="795" src="https://hitconsultant.net/wp-content/uploads/2026/04/Wavelet-Medical-Advanced-Fetal-Brain-Monitoring-1500x795.jpg" alt="Yale Startup Wavelet Medical Raises $7M to Optimize Fetal Brain Monitoring Wavelet Medical Raises $7M Seed Round with Aegis Ventures for Non-Invasive Fetal EEG Platform Wavelet Medical Secures $7M Seed Round to Scale AI Fetal Monitoring Globally" class="wp-image-95760" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/Wavelet-Medical-Advanced-Fetal-Brain-Monitoring-1500x795.jpg 1500w, https://hitconsultant.net/wp-content/uploads/2026/04/Wavelet-Medical-Advanced-Fetal-Brain-Monitoring-300x159.jpg 300w, https://hitconsultant.net/wp-content/uploads/2026/04/Wavelet-Medical-Advanced-Fetal-Brain-Monitoring-290x154.jpg 290w, https://hitconsultant.net/wp-content/uploads/2026/04/Wavelet-Medical-Advanced-Fetal-Brain-Monitoring-768x407.jpg 768w, https://hitconsultant.net/wp-content/uploads/2026/04/Wavelet-Medical-Advanced-Fetal-Brain-Monitoring-1536x814.jpg 1536w, https://hitconsultant.net/wp-content/uploads/2026/04/Wavelet-Medical-Advanced-Fetal-Brain-Monitoring.jpg 1844w" sizes="(max-width: 1500px) 100vw, 1500px" /> What You Should Know The Raise & Partnership: Wavelet Medical, an AI-powered fetal brain monitoring startup spun out of Yale, has raised $7M in seed funding and entered into a co-creation partnership with the venture studio Aegis Ventures. The Solution: Wavelet has developed the first non-invasive, AI-powered fetal electroencephalography (EEG) monitoring platform. Instead of looking at the heart, Wavelet measures the organ that directly reflects neurological status: the brain. The Tech Architecture: The device uses sensors placed on the mother’s abdomen. Proprietary AI algorithms—engineered by co-founder and Head of Science Dr. Jose Cortes-Briones—reconstruct the fetal EEG from these abdominal signals to identify auditory-evoked brain responses that signal neurological distress in rea…

Finding the Right Five Percent: How Machine Learning Is Reshaping Care Management
type: item
creator: Mary Bacaj, Ph.D., President of Value-Based Care at Conifer Health Solutions
date: 2026-04-14T07:00:00Z
subject: Health IT
subject: Opinion
subject: Policy
subject: Population Health Management
subject: Value-Based Care
description: Population Health Has a Precision Problem Population health programs continue to rely on blunt tools. Many risk stratification approaches emphasize historical utilization—basic risk scores or vendor-generated models that explain who was expensive—rather than identifying emerging clinical risk. These methods struggle to detect deterioration early enough to influence outcomes. At the same time, care management teams face persistent ... Read More
encoded: Mary Bacaj, Ph.D., President of Value-Based Care at Conifer Health Solutions Population Health Has a Precision Problem Population health programs continue to rely on blunt tools. Many risk stratification approaches emphasize historical utilization—basic risk scores or vendor-generated models that explain who was expensive—rather than identifying emerging clinical risk. These methods struggle to detect deterioration early enough to influence outcomes. At the same time, care management teams face persistent resource constraints. Organizations cannot provide intensive support to every member. Clinical capacity must be allocated deliberately, and success depends on identifying which members need intervention early—before preventable hospitalizations and escalating costs occur. Clinical Informatics Meets Analytics The difference between managing volume and managing risk is anticipation. Effective population health programs must estimate disease severity and future cost before clinical decline occurs. Predictive accuracy has become both a clinical and financial necessity. This has led some organizations to integrate clinical informatics more directly into analytic development. When clinical reasoning informs how models are built—and analytics, in turn, inform care strategy—risk identification becomes more actionable. Rather than treating predictive models as static tools layered onto workflows, this approach allows care management strategy and analytic design to evolve together. From Claims to Disease A growing body of work supports a disease-centered view of risk. Traditional analytics treat claims as isolated events, counting visits, procedures, or prescriptions as separate indicators of utilization. In contrast, disease-based approaches aggregate medical and pharmacy claims into unified profiles that reflect how conditions progress over time. For example, laboratory testing, neuropathy treatment, specialist visits, and medication patterns can be evaluated as components…

Ultralight Raises $9.3M to Launch AI-Native Operating System for Healthcare
type: item
creator: Fred Pennic
date: 2026-04-14T00:56:04Z
subject: Digital Health
subject: Health IT
subject: Startups
description: What You Should Know: The Rebrand and Raise: Vibrant Practice has officially rebranded to Ultralight and announced a $9.3M funding round to build an AI-native operating system for modern medicine. The Backers: The round was led by The General Partnership, with participation from Wisdom Ventures, Anthemis Group, Emerson Collective, GSBackers, and notable angel investors, including ... Read More
encoded: <img loading="lazy" width="1500" height="1215" src="https://hitconsultant.net/wp-content/uploads/2026/04/ultralight-1500x1215.jpg" alt="" class="wp-image-95753" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/ultralight-1500x1215.jpg 1500w, https://hitconsultant.net/wp-content/uploads/2026/04/ultralight-300x243.jpg 300w, https://hitconsultant.net/wp-content/uploads/2026/04/ultralight-290x235.jpg 290w, https://hitconsultant.net/wp-content/uploads/2026/04/ultralight-768x622.jpg 768w, https://hitconsultant.net/wp-content/uploads/2026/04/ultralight-1536x1244.jpg 1536w, https://hitconsultant.net/wp-content/uploads/2026/04/ultralight.jpg 1573w" sizes="(max-width: 1500px) 100vw, 1500px" /> What You Should Know: The Rebrand and Raise: Vibrant Practice has officially rebranded to Ultralight and announced a $9.3M funding round to build an AI-native operating system for modern medicine. The Backers: The round was led by The General Partnership, with participation from Wisdom Ventures, Anthemis Group, Emerson Collective, GSBackers, and notable angel investors, including former Surgeon General Vivek Murthy. The DPC Tipping Point Direct Primary Care (DPC) practices tripled among family physicians in a single year. Consumers are driving a $6.8 trillion wellness economy, voting with their wallets for physicians who actually know them. Furthermore, DPC memberships are now HSA-eligible, removing a massive financial barrier for patients seeking continuous, personalized care. However, running these modern, subscription-based clinics on legacy software designed for fee-for-service billing is incredibly painful. Technology in the exam room has historically felt heavy and cumbersome, turning highly trained physicians into data-entry clerks who spend their evenings charting. Technology That Feels “Ultralight” Healthcare technology shouldn’t feel heavy, cumbersome, or intrusive. The company’s new name, Ultralight, represents what we believe medical tech should be: Invisible Inf…

The AI Arms Race: Why PHTI Warns Healthcare ‘Bot Wars’ Are Inflating Medical Costs
type: item
creator: Fred Pennic
date: 2026-04-14T00:27:20Z
subject: Health IT
description: What You Should Know: – A newly released report from the Peterson Health Technology Institute finds that while AI is reducing administrative burden for individual organizations, it is not lowering system-wide costs—and may, in fact, be increasing them. – The reason: AI is accelerating activity across the system—more prior authorization submissions, more billing complexity, and ... Read More
encoded: <img loading="lazy" width="811" height="952" src="https://hitconsultant.net/wp-content/uploads/2026/04/PHTI-Report.jpg" alt="" class="wp-image-95750" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/PHTI-Report.jpg 811w, https://hitconsultant.net/wp-content/uploads/2026/04/PHTI-Report-256x300.jpg 256w, https://hitconsultant.net/wp-content/uploads/2026/04/PHTI-Report-247x290.jpg 247w, https://hitconsultant.net/wp-content/uploads/2026/04/PHTI-Report-768x902.jpg 768w" sizes="(max-width: 811px) 100vw, 811px" /> What You Should Know: – A newly released report from the Peterson Health Technology Institute finds that while AI is reducing administrative burden for individual organizations, it is not lowering system-wide costs—and may, in fact, be increasing them. – The reason: AI is accelerating activity across the system—more prior authorization submissions, more billing complexity, and more back-and-forth between providers and payers—without fixing the underlying structural inefficiencies. The Prior Authorization “Bot War” Prior authorization is a significant source of friction, with each submission cycle costing health plans $40–$50 and providers $20–$30. While AI is being deployed to automate these tasks, it has yet to reduce overall system-level costs. Increased Activity, Not Efficiency: AI allows providers to submit more requests and plans to process more denials, leading to “bot wars”—automated back-and-forth exchanges that increase communication volume without resolving the underlying clinical questions. The Scalability Gap: Emerging real-time adjudication models aim to approve requests during a patient visit, but these proofs of concept remain narrow and difficult to scale due to fragmented medical policies across different health plans. Standardization Limits: While new rules like CMS-0057-F mandate data standards for APIs, they do not standardize the actual medical necessity criteria, which vary wildly between insurers. Medical Billing and the Risk of…

ModMed Expands Multi-Year Cloud Agreement with AWS to Scale Healthcare AI Solutions
type: item
creator: Jasmine Pennic
date: 2026-04-13T14:00:00Z
subject: Digital Health
subject: Health IT
description: What You Should Know ModMed, a massive provider of specialty-specific EHRs, has signed a new multi-year agreement with Amazon Web Services (AWS). AWS has been ModMed’s primary cloud provider since its inception, but this expanded agreement specifically designates AWS as the engine for ModMed’s “AI-Powered Practice” initiative. The Clinical Vision The goal of the expanded ... Read More
encoded: <img loading="lazy" width="1500" height="431" src="https://hitconsultant.net/wp-content/uploads/2025/08/IMG_4685-1500x431.jpeg" alt="ModMed Launches AI-Powered Enhanced Faxing for EMA®, Reducing Admin Time by 80%" class="wp-image-90677" srcset="https://hitconsultant.net/wp-content/uploads/2025/08/IMG_4685-1500x431.jpeg 1500w, https://hitconsultant.net/wp-content/uploads/2025/08/IMG_4685-300x86.jpeg 300w, https://hitconsultant.net/wp-content/uploads/2025/08/IMG_4685-290x83.jpeg 290w, https://hitconsultant.net/wp-content/uploads/2025/08/IMG_4685-768x221.jpeg 768w, https://hitconsultant.net/wp-content/uploads/2025/08/IMG_4685-1536x441.jpeg 1536w, https://hitconsultant.net/wp-content/uploads/2025/08/IMG_4685-2048x589.jpeg 2048w" sizes="(max-width: 1500px) 100vw, 1500px" /> What You Should Know ModMed, a massive provider of specialty-specific EHRs, has signed a new multi-year agreement with Amazon Web Services (AWS). AWS has been ModMed’s primary cloud provider since its inception, but this expanded agreement specifically designates AWS as the engine for ModMed’s “AI-Powered Practice” initiative. The Clinical Vision The goal of the expanded partnership is to embed AI—such as the generative AI tool ModMed Scribe 2.0—into every corner of a specialty medical practice, including clinical documentation, billing, front-office operations, and patient engagement. When a dermatologist or an ophthalmologist uses an ambient listening tool like ModMed Scribe 2.0, that audio must be instantly processed, securely analyzed, mapped to the correct medical codes, and inserted into the EHR without a second of latency. Multiply that action across nearly 50,000 providers. Supported by AWS, ModMed’s architecture is now processing over 3 petabytes of data each month. This translates to over 107 million hours of cluster processing monthly, handling hundreds of millions of clinical notes, patient messages, and practice performance metrics. “In healthcare, providers need technology they can trust…

symplr Appoints Former Edifecs Executive Venkat Kavarthapu as CEO
type: item
creator: Healthcare Executive Hires
date: 2026-04-13T13:56:00Z
subject: Digital Health
subject: Health IT
subject: Digital Health Hires
description: What You Should Know The Appointment: Enterprise healthcare operations software giant symplr has appointed Venkat Kavarthapu as its new Chief Executive Officer, effective immediately. The Leadership Transition: Kavarthapu succeeds Chris Colpitts, who had been serving as interim CEO since November 2025. Colpitts will remain heavily involved, maintaining his role as Executive Chairman of the Board. ... Read More
encoded: <img loading="lazy" width="400" height="402" src="https://hitconsultant.net/wp-content/uploads/2026/04/Venkat-Kavarthapu-Hex.png" alt="symplr Appoints Former Edifecs Executive Venkat Kavarthapu as CEO" class="wp-image-95743" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/Venkat-Kavarthapu-Hex.png 400w, https://hitconsultant.net/wp-content/uploads/2026/04/Venkat-Kavarthapu-Hex-290x290.png 290w, https://hitconsultant.net/wp-content/uploads/2026/04/Venkat-Kavarthapu-Hex-100x100.png 100w" sizes="(max-width: 400px) 100vw, 400px" /> Venkat Kavarthapu, CEO at symplr What You Should Know The Appointment: Enterprise healthcare operations software giant symplr has appointed Venkat Kavarthapu as its new Chief Executive Officer, effective immediately. The Leadership Transition: Kavarthapu succeeds Chris Colpitts, who had been serving as interim CEO since November 2025. Colpitts will remain heavily involved, maintaining his role as Executive Chairman of the Board. Kavarthapu Background Kavarthapu is a 25-year veteran of health-tech, but he most recently served as the CEO of Edifecs, a major interoperability and health data management platform. He didn’t just scale Edifecs; he successfully shepherded the company through its high-profile acquisition by Cotiviti in 2025. He proved he can navigate complex enterprise integrations while delivering massive financial returns for his backers. “Venkat’s success in scaling healthcare technology platforms and delivering practical, data-driven innovation makes him the right leader to drive symplr’s new phase of growth,” noted Prashant Mehrotra (Clearlake) and Ryan Carroll (Charlesbank) in a joint statement. Backed by private equity heavyweights Clearlake Capital Group and Charlesbank Capital Partners, Kavarthapu’s primary mandate is to scale symplr’s adoption and aggressively push “AI-powered innovation” across its massive customer base.

The Push for Side-by-Side Prescription Pricing in EHR Workflows
type: item
creator: Lathe Bigler, SVP, Business Strategy, Buzz Health
date: 2026-04-13T06:59:00Z
subject: Digital Health
subject: EMR/EHR
subject: Health IT
subject: Opinion
description: Prescribing has evolved into a financial decision as much as a clinical one. As a result, one of the most consequential access moments is now occurring inside the electronic health record (EHR) during the prescribing workflow, when cost information surfaces and treatment decisions are finalized. As affordability pressures intensify across commercial, Medicare, and Medicaid populations, ... Read More
encoded: <img loading="lazy" width="1182" height="665" src="https://hitconsultant.net/wp-content/uploads/2026/04/Lathe-Bigler.jpeg" alt="The Push for Side-by-Side Prescription Pricing in EHR Workflows" class="wp-image-95727" srcset="https://hitconsultant.net/wp-content/uploads/2026/04/Lathe-Bigler.jpeg 1182w, https://hitconsultant.net/wp-content/uploads/2026/04/Lathe-Bigler-300x169.jpeg 300w, https://hitconsultant.net/wp-content/uploads/2026/04/Lathe-Bigler-290x163.jpeg 290w, https://hitconsultant.net/wp-content/uploads/2026/04/Lathe-Bigler-768x432.jpeg 768w" sizes="(max-width: 1182px) 100vw, 1182px" /> Lathe Bigler, SVP, Business Strategy, Buzz Health Prescribing has evolved into a financial decision as much as a clinical one. As a result, one of the most consequential access moments is now occurring inside the electronic health record (EHR) during the prescribing workflow, when cost information surfaces and treatment decisions are finalized. As affordability pressures intensify across commercial, Medicare, and Medicaid populations, patient out-of-pocket costs have become a primary driver of whether therapy is initiated or abandoned. Our recent survey of prescribers and technology leaders revealed how deeply the affordability discussion is influencing prescribing decisions. Pricing information is increasingly visible at the point of prescribing, yet fulfillment outcomes remain uncertain. That disconnect carries implications for adherence, pharmacy operations, and overall healthcare costs. Prioritizing Cost Discussions Medication cost is no longer a secondary consideration for patients. In the survey, 75% of prescribers report that potential out-of-pocket spending is a major or moderate barrier to patients starting or continuing therapy. Cost conversations are frequent: 77.2% of prescribers report being asked about medication expenses weekly or more often during patient visits. These figures indicate that affordability pressures are now a structural feature of clinical care.…